All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

CME Not Likely To Focus On OTC

Craig Donohue, ceo of CME Group, said it is unlikely that over-the-counter derivatives will become the focus of the firm’s activity, even as the instruments move to central clearing.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree